J A Mancini - JoVE Visualize

Showing results (31-40 of 45) with videos related to

Pageof 5

Sort By:

American Journal of Physiology. Renal Physiology|November 13, 2001

Urogenital distribution of a mouse membrane-associated prostaglandin E(2) synthaseY Guan, Y Zhang, A Schneider, et al.

Molecular Pharmacology|February 1, 1992

5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitorsJ A Mancini, P Prasit, M G Coppolino, et al.

FEBS Letters|March 8, 1993

5-lipoxygenase-activating protein is an arachidonate binding proteinJ A Mancini, M Abramovitz, M E Cox, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 15, 2004

Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitorD Claveau, S L Chen, S O'Keefe, et al.

Molecular Pharmacology|July 1, 1991

5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitorsJ F Evans, C Lévillé, J A Mancini, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 2006

Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitisC S Moore, N Earl, R Frenette, et al.

Molecular Pharmacology|November 14, 1997

The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugsG M Greig, D A Francis, J P Falgueyret, et al.

Journal of Lipid Mediators|May 1, 1993

Leukotriene synthesis in U937 cells expressing recombinant 5-lipoxygenaseS Kargman, P Rousseau, G K Reid, et al.

Molecular Pharmacology|February 1, 1994

Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acidG P O'Neill, J A Mancini, S Kargman, et al.

Agents and Actions. Supplements|January 1, 1995

Selective inhibitors of COX-2G P O'Neill, B P Kennedy, J A Mancini, et al.

Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:

Pageof 5

American Journal of Physiology. Renal Physiology|November 13, 2001

Urogenital distribution of a mouse membrane-associated prostaglandin E(2) synthaseY Guan, Y Zhang, A Schneider, et al.

Molecular Pharmacology|February 1, 1992

5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitorsJ A Mancini, P Prasit, M G Coppolino, et al.

FEBS Letters|March 8, 1993

5-lipoxygenase-activating protein is an arachidonate binding proteinJ A Mancini, M Abramovitz, M E Cox, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 15, 2004

Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitorD Claveau, S L Chen, S O'Keefe, et al.

Molecular Pharmacology|July 1, 1991

5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitorsJ F Evans, C Lévillé, J A Mancini, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 2006

Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitisC S Moore, N Earl, R Frenette, et al.

Molecular Pharmacology|November 14, 1997

The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugsG M Greig, D A Francis, J P Falgueyret, et al.

Journal of Lipid Mediators|May 1, 1993

Leukotriene synthesis in U937 cells expressing recombinant 5-lipoxygenaseS Kargman, P Rousseau, G K Reid, et al.

Molecular Pharmacology|February 1, 1994

Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acidG P O'Neill, J A Mancini, S Kargman, et al.

Agents and Actions. Supplements|January 1, 1995

Selective inhibitors of COX-2G P O'Neill, B P Kennedy, J A Mancini, et al.

Pageof 5